FGF19 and hepatocellular carcinoma: Indeed, FGF19 expressing transgenic mice exhibit increased hepatic BrdU incorporation and elevated expression of α-fetoprotein (AFP) mRNA, a marker for hepatocyte proliferation, as early as 2 months of age, and go on to spontaneously develop hepatocellular carcinomas [15].